Literature DB >> 27957087

Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction.

Petras Stirbys1.   

Abstract

Atrial fibrillation (AF) as the most common supraventricular arrhythmia is scarcely amenable to contemporary treatment. Due to the diverse origin and variable clinical course of AF there is a broad spectrum of therapy options. However, optimal AF management has not become a gold standard yet. In general, the recurrence rate of AF is most often clinically unacceptable despite drug, surgical and/or ablation therapy. Substrate-based approach and ongoing ablation of atrial wall in its selected areas including the vicinity of pulmonary veins can be harmful. Applied physical factors do produce total disintegration of cardiomyocites - both intra- and inter-cellular damage which, in turn, leads to functional hypo-/inactivation of atria irrespective of whether the sinus rhythm is restored or not. In fact, iatrogenic phenomenon of ablation-induced atrial incompetence did emerge. Heterogeneity in clinical results reflects the uncertainty regarding the efficacy, risks and benefits of invasive AF therapy. In this regard the overall burden of AF may increase when using current therapy methods. Applicability of destructive techniques is yet to be fully elucidated and discussed. We hypothesize that currently used ablation and/or surgical techniques are potentially harmful since the success rates are likely achieved through violation of atrial myocardium. That is why a new and well-designed therapeutic strategy is needed. Invention of highly selective curative methods producing fibrillatory/electric blockage with concomitant saving of atrial transport function is to be encouraged.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Cytocidal effect; Destruction; Hybrid therapy; Parkinsonism; Surgical

Year:  2014        PMID: 27957087      PMCID: PMC5135156          DOI: 10.4022/jafib.1082

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  67 in total

Review 1.  Antiarrhythmic therapy in atrial fibrillation.

Authors:  Ursula Ravens
Journal:  Pharmacol Ther       Date:  2010-07-17       Impact factor: 12.310

2.  Surgical ablation of atrial fibrillation after the PRAGUE-12 study: more questions than answers.

Authors:  Gerhard Hindricks; Christopher Piorkowski
Journal:  Eur Heart J       Date:  2012-08-28       Impact factor: 29.983

Review 3.  Cell-to-cell communication in the heart: structure-function correlations.

Authors:  J Délèze
Journal:  Experientia       Date:  1987-10-15

4.  Evidence for increased atrial sympathetic innervation in persistent human atrial fibrillation.

Authors:  Paul A Gould; Michael Yii; Catriona McLean; Samara Finch; Tanneale Marshall; Gavin W Lambert; David M Kaye
Journal:  Pacing Clin Electrophysiol       Date:  2006-08       Impact factor: 1.976

5.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

6.  Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Andrea M Russo; Hemal Nayak; David Lin; Ward Pulliam; Sultan Siddique; Francis E Marchlinski
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

Review 7.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

8.  Time to recurrence of atrial fibrillation influences outcome following catheter ablation.

Authors:  Larraitz Gaztañaga; David S Frankel; Maria Kohari; Lavanya Kondapalli; Erica S Zado; Francis E Marchlinski
Journal:  Heart Rhythm       Date:  2012-09-14       Impact factor: 6.343

9.  Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study.

Authors:  Thomas Arentz; Reinhold Weber; Gerd Bürkle; Claudia Herrera; Thomas Blum; Jochem Stockinger; Jan Minners; Franz Josef Neumann; Dietrich Kalusche
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  Atrial tachycardia after ablation of persistent atrial fibrillation: identification of the critical isthmus with a combination of multielectrode activation mapping and targeted entrainment mapping.

Authors:  Anshul M Patel; Andre d'Avila; Petr Neuzil; Steven J Kim; Theofanie Mela; Jagmeet P Singh; Jeremy N Ruskin; Vivek Y Reddy
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.